Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 526 to 550
-
Meeting statementsAdvisory Committee on Medical Devices
-
Scheduling decisions (final)Final decisions and reasons for matters referred to ACCS#20, ACMS #21 (July 2017 meetings) and Joint ACCS-ACMS #15 and #16 (March and July 2017meetings).
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 10 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 7 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 8 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 9 statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 3 October 2017
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 17 meeting statement
-
Meeting statementsACMD 31 meeting statement has been published
-
Meeting statementsACM 1 meeting statement has been published
-
Scheduling decisions (final)Final decisions for medicines and chemicals referred to March 2017 scheduling meetings (ACMS #20, ACCS #19 and Joint ACMS-ACCS #15) and NCEs.
-
Scheduling decisions (final)New Chemical Entity (NCE) delegate's final decision and reasons for decision for brexpiprazole
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 31 May 2017
-
Meeting statementsACMD meeting statement, Meeting 25, 26 February 2016
-
Meeting statementsACMD meeting statement, Meeting 26, 29 April 2016
-
Meeting statementsACMD meeting statement, Meeting 27, 24 June 2016
-
Meeting statementsACMD meeting statement, Meeting 28, 26 August 2016
-
Meeting statementsACMD meeting statement, Meeting 29, 21 October 2016
-
Meeting statementsACMD meeting statement, Meeting 30, 2 December 2016
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 23 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 24 statement
-
Scheduling decisions (final)Delegate-only final decisions to amend the Poisons Standard not referred to an expert advisory committee.
-
PublicationsThe TGA's scientific review on the safety of nanoparticles in sunscreens has been updated.
-
PublicationsEconomic modelling and financial quantification of the regulatory impact of proposed changes to codeine scheduling